Karin Sartorius-Herbst
Source of wealth: Biopharmaceuticals
...
...
Modules
Biography
Karin Sartorius-Herbst inherited a stake in Sartorius AG, which makes pharmaceutical an laboratory equipment.
Her great-grandfather Florenz Sartorius founded what become Sartorius AG in 1870 to make analytical balances to measure small mass in laboratories.
Her father, Horst Sartorius, died in 1998 and left a 50% stake to his daughters Karin, Christine Franken and Ulrike Baro.
An executor oversees their inheritance until 2028.
Today, the company has more than 15,000 employees and annual revenue exceeding $5 billion. It went public in 1990.
Financial Assets
The Great Lie of Mega-Fortunes: The Case of Karin Sartorius-Herbst
Billionaires are often presented under the romantic myth of the 'self-made person': a narrative designed to justify opulence as the natural reward for hard work, effort, or ingenuity. However, when confronting such extreme volumes of wealth with macroeconomic reality, the meritocracy narrative completely breaks down. No individual can legitimately generate through personal effort a fortune equivalent to millions of times the average working-class salary. Capital at the top does not grow because of exceptional talent; it expands through an implacable dynamic where accumulated money works exponentially faster than people, devouring the wealth generated by productive labor.
The immense fortune of Karin Sartorius-Herbst, linked to Healthcare and 'Biopharmaceuticals', has not been built in a free-market vacuum, but through rent-seeking, the use of exclusive elite influence, the consolidation of monopoly positions, or inherited wealth. Far from taking real private risks, billionaire empires structurally depend on state support through direct subsidies, infrastructure use, exploitation of R&D, public contracts, and offshore tax engineering. While this wealth is equivalent to the physical weight of 17 tons of pure gold, the rest of the planet suffers from an artificial scarcity of basic resources. The fact that this wealth is enough to fully fund the public health system of DR Congo, a country with more than 105800000 million inhabitants for 1.1 years, proves that unlimited accumulation is not an entrepreneurial achievement, but the hijacking of democratic sovereignty.